With a CAGR of more than 5.4%, the market for scabies treatment is expected to grow from a value of around US$ 217.49 million in 2022 to more than US$ 368 million by 2032.
| Report Attribute | Details |
|---|---|
| Scabies Treatment market Value (2022) | US$ 217.49 Million |
| Scabies Treatment market Anticipated Value (2032) | US$ 368 Million |
| Scabies Treatment market Growth Rate (2022 to 2032) | 5.4% CAGR |
Scabies is an infectious skin disease caused by microscopic mites known as Sarcoptes scabiei, that lives inside human skin. The mites burrows into the skin and lay eggs after staying for two to three weeks. Scabies is an itchy, rash and pimple like skin disease condition found, globally.
Scabies is a highly contagious disease and can pass through simple contact with affected person. The disease is pruritic in nature. The common sites for the rash are wrist elbow, armpit, waist, area between the fingers.
Combination medicines are prescribed by physician are permethrin cream, benzyl benzoate lotion, crotamiton cream, sulfur ointment and one percent lindane lotion. In some caritical condition the patient has been prescribed with antihistamines, antibiotics and steroid creams. The more aggressive treatment in worst cases anthelmintic is given orally.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The main drivers of the expansion of the scabies treatment market include the rising demand for targeted therapies, an increase in research and development efforts for the creation of novel drugs and treatments, a high prevalence of skin disorders, the disease's high contagiousness, and rising costs for the construction of healthcare infrastructure.
Scabies are becoming more common all around the world, and people are becoming more aware of their treatment options, which is a key driver of market expansion. Other reasons contributing to the industry's expansion include rising infrastructure development costs, poor population cleanliness, and an increase in the level of strategic cooperation among market participants. Another indirect factor that will produce profitable market growth potential is rising personal disposable income.
The development of the market will be significantly hampered by the abundance of homecare treatments and the unfavorable reimbursement environment in developing and underdeveloped economies. The market growth rate will be further slowed down by high research and development expenses as well as pharmacological side effects. The market growth rate will be hampered by the strict rules put in place for the approval of medications on the market.
Through technological innovation and advancement, the product's performance will be further optimised, boosting its use in downstream applications. Additionally, market dynamics (drivers, restraints, opportunities) and consumer behaviour analysis provide essential data for understanding the market for scabies treatments.
One of the key factors fueling the growth of the scabies treatment market over the coming years, according to the Scabies Treatment Market, is the rise in R&D spending on therapeutic vaccines. Additionally, due to enhanced disease diagnostic techniques and expanding research on combination medicines, there will be a significant increase in demand.
With technological advancements, rising healthcare spending, and bettering healthcare infrastructure and systems, the pharmaceutical and healthcare industries are expanding quickly. Many hospitals, ambulatory surgical centers, and clinics are incorporating cutting-edge technologies worldwide. The prevalence of chronic diseases is on the rise, healthcare and medical technology is advancing quickly, the global market for scabies treatments is adopting the newest tools and techniques at a high rate, and both public and private sectors are increasing their funding. These factors are all contributing to the market's revenue growth.
Additionally, throughout the forecast period, rising investments in research & development activities, rising need for precision medicine, high adoption of home care settings and point-of-care diagnostics, and rising focus on medication development are anticipated to propel global market revenue growth.
The dynamics of the pharmaceutical and healthcare industries are drastically shifting due to the ongoing epidemic. Many nations are dealing with issues such a lack of medications, vaccines, and medical equipment in hospitals. In the upcoming years, this is anticipated to present industry players with profitable growth chances.
Principal Consultant
Due to its extensive population and high incidences of infectious disorders, Asia-Pacific dominates the global market for scabies treatments. During the forecast period, significant gains are anticipated for Asia-Pacific. This is due to rising infrastructure development costs for the healthcare system and rising personal disposable income.
Consumption levels, manufacturing locations and volumes, import-export analysis, price trend analysis, cost of raw materials, and upstream and downstream value chain analyses are a few of the important data points utilized to evaluate the market scenario for nations. It also considers trade routes, the impact of domestic tariffs, the presence and accessibility of international brands, the challenges they face due to strong or weak competition from local and domestic brands, and their presence and accessibility of international brands when providing forecast analysis of the country data.
According to the World Health Organization, there are 300 million cases of scabies globally every year. The market is driven in Pacific and Latin America due to high prevalence. Scabies market is expected to rise in countries having majority of young population like all the developing countries.
The environmental factors are responsible for the scabies and will be driving the scabies treatment market during the forecast period. The homecare remedies can be a restraint as they will hinder the market of medications available on prescriptions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Scabies Treatment Market is account to expand at promising CAGR during the forecast period due to its high prevalence rate across the globe. Extensive spreading of disease will also play an important role in expanding the market.
Growth rate for scabies treatment will be rising substantially due to increase in investment on healthcare sector by the pharmaceutical companies which will mark the specificity of the disease and also help in increasing awareness level for scabies.
Geographically, scabies treatment market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, , Asia Pacific Excl Japan, Japan, and Middle East & Africa. North America accounts for high market share in scabies treatment market as approximately one million of affected including all age groups and sex and socio-economic status followed by Western and Eastern Europe including Middle east and Africa where the prevalence is greater than 10 per cent, although Asia Pacific and Latin America has comparatively more prevalent in children than from adults.
Japan having less population with other hygienic facilities, the market here is here is stable. Overall the market share for scabies treatment will be rising as approximately 300 million people are reported with scabies around the world every year.
There are many key performers in Scabies Treatment market some of the names who are leading the market in Scabies Treatment worldwide are Renaissance Pharma Inc, Merck & Co., Ranbaxy Laboratories Inc., and others
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.
The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Scabies Treatment is classified on the basis of drug administration type and disease type:
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Analysis and Forecast 6.1. Medication Type 6.2. Drug Administration Type 7. Global Analysis and Forecast, By Medication Type 7.1. Ointment 7.2. Gel 7.3. Creams 7.4. Lotions 7.5. Combinational medicines 7.6. Permethrin Cream 7.7. Benzyl Benzoate Lotion 7.8. Sulfur Ointment 7.9. Crotamiton Cream 7.10. Lindane Lotion 7.11. Other medicine 7.12. Ivermectin 8. Global Analysis and Forecast, By Drug Administration Type 8.1. Oral 8.2. Topical 9. Global Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. Asia Pacific 9.6. Japan 9.7. Middle East and Africa 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. Japan Sales Analysis and Forecast, by Key Segments and Countries 16. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Medication Type and Drug Administration Type for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Renaissance Pharma Inc 19.2. Merck & Co. 19.3. Ranbaxy Laboratories Inc. 19.4. Others
Explore Healthcare Insights
View Reports
Scabies Treatment Market
